Welcome to our Q1 2025 Newsletter, which includes the following features:
Fund I Update
Continuation of Fund I in progress
BSV CEO Summit
Highlights from the 3rd Annual CEO Summit
Impressive Traction by Our Portfolio Companies
Luna – Series C expected to close June 1
Wheeler Bio – Raises $35M Series B to scale manufacturing
Lumata Health – Expands partnerships after $23M Series B
Myri Health – Enters GCC region with MOUs and payer traction
VesprSolar – Unveils solar attachments at RE+
Exum Instruments – Prepares Series B, building strategic relationships
Cadenza Bio – Advances oncology pipeline, Series A raise underway
Vinsense – Finalizes partnerships, extends bridge round for growth
BSV Welcomes New Advisors
Dr. Rachel-Yvonne Talton
Dr. Marnie Peterson
Dr. L. Bernard Jones Jr.
Anthony Jackson
GP highlights
Find out what our GP James Spann has been up to
BSV Advisor Profile
Lisa Risser – Launches Fearless Money Management
Sowmya Sridhar – Joins Women Executives on Boards
We hope you enjoy this issue!
Fund I Update
We’re excited to announce that Boyd Street Ventures Fund I has been officially extended through December 31, 2025. This continuation reflects both the strong momentum across our portfolio and ongoing investor interest. The extension provides additional runway to support our most promising early-stage companies and to welcome new strategic partners aligned with our mission of uncovering and accelerating under-the-radar innovation from the heartland.
If you’re interested in participating or would like more information, please schedule a call below.
In April, we hosted our 3rd Annual CEO Summit in Norman, Oklahoma, uniting founders, advisors, and capital partners from across our network. This year’s programming emphasized leadership development, capital formation, and startup scalability.
Highlights:
Scaling Strategically – Real-world founder stories on growth
Fundraising Masterclass – Pitching and closing institutional capital
Culture Eats Strategy – Tactics for building high-performance teams
Venture Studio 2.0 – Deep dive into BSV’s unique support model
Capital Perspectives Panel – VC, Family Office, and Fund-of-Fund insights
Founder Roundtables – Peer-to-peer sessions on GTM, hiring, and traction
Thank you to our incredible portfolio leaders and community for making this a standout event.
Advisory Board Update:
Welcoming New Strategic Advisors
We are excited to welcome four exceptional leaders to the Boyd Street Ventures Advisory Board:
Dr. Rachel-Yvonne Talton – is the Founder and CEO of Synergy International, a consultancy that leverages research-driven strategies to foster inclusive leadership and organizational growth, and also serves as Chief Transformation Officer of Flourish Leadership, empowering women executives through executive coaching and retreats . LinkedIn →
Dr. Marnie Peterson, PharmD, PhD –, is an expert in experimental therapeutics with a strong track record in drug discovery and development, holding multiple patents and NIH-funded research in antimicrobial and vaccine technologies. LinkedIn →
Dr. L. Bernard Jones, Jr. MBA, Doctor of Computer Science, CISM, – is a seasoned global information cybersecurity professional currently at PwC, with a strong background in banking cyber risk management, regulatory, and information security. LinkedIn →
Anthony Jackson, PharmD- is the Chief Pharmacy Officer at Scripps Health, overseeing pharmacy supply chain, hospital and ambulatory operations, oncology programs, and residency training, with over 30 years of experience in health systems. LinkedIn →
Thank You to Our Departing Advisors
With deep appreciation, we recognize the contributions of our departing advisors, whose early belief helped shape our foundation:
John W. Sheets, Jr. – President & CEO, Pantheon Vision LinkedIn →
Sharen Jester Turney – Former President & CEO, Victoria’s Secret LinkedIn →
Ryan Martinez – Oklahoma State Representative LinkedIn →
Quintin D. Hughes, Sr - Founder & Executive Director, Northeast Oklahoma City Renaissance Inc. (NEOKCR); Member, Community Development Advisory Council, Federal Reserve Bank of Kansas City LinkedIn →
Impressive Traction by Our Portfolio Companies
We're pleased to report that our 16 portfolio companies are generating impressive momentum. Here are several examples:
Luna anticipates closing Series C close on June 1. Luna enters 2025 as a category leader in at home physical therapy. Over the past year, Luna has scaled operations across 55 metro markets and 28 states. Luna employes over 3500 therapists, serves roughly 20,000 patients per quarter, and delivers 53,000 plus visits per month (1 visit every 11 seconds). With recent patient care preference surveys revealing a clear propensity for in-person at-home care, Luna is poised for continued growth in 2025.Recent Luna accolades: Forbes voted Luna #3 on the “Best Employer in Healthcare” 2025, and Fast Company voted Luna #13 on the “Most Innovative Company In Healthcare” 2025. Learn more about Luna→
Wheeler Bio Raises $35M Series A-1 to Scale Biomanufacturing Platform
Wheeler Bio has successfully closed an oversubscribed $35 million Series A-1, accelerating its mission to streamline biologics development through its CTPD™ platform. This funding will support the expansion of manufacturing capacity and strategic partnerships, helping biopharma clients bring new therapies to market faster and more affordably. Read More →
Lumata Health Closes $23M Series B and Expands Strategic Partnerships
Lumata Health is scaling rapidly after raising $23M in Series B funding and expanding its reach through partnerships with EyeCare Partners, ESP, and RCA. Highlights include:
27,000+ patients enrolled (44% QoQ growth)
63% QoQ revenue growth
Team scaled to 200+ FTEs
Increased care efficiency and new billing integrations Lumata is actively recruiting for a CTO to lead their next stage of tech infrastructure growth. Press Release →
Myri Health Expands into Middle East, Onboards Health Plans
Myri Health is going global. The maternal care platform has launched in Abu Dhabi and Riyadh, signing MOUs across Oman, UAE, and Saudi Arabia. Key milestones include:
Integration with payer workflows, billing, and population health tools
Enhanced platform with Maya AI assistant, PlatePal nutrition insights, and wearable syncing
Added advisory talent from Johns Hopkins-affiliated systems, global health ministries, and tech giants like Linktree, Snapchat, and WHOOP
Selected to present at the World 50 Accelerator Spring Summit, alongside Baylor Scott & White, Cleveland Clinic, and Emory Healthcare
Myri continues to scale its infrastructure, care coordination tools, and payer distribution while soft-circling capital for the next phase of growth. Learn more about Myri Health→
VesprSolar Launches Groundbreaking Solar Attachments at RE+
VesprSolar unveiled its high-performance, low-penetration solar attachments at RE+ 2024, delivering a faster, more reliable racking solution for commercial solar deployments. These innovations reduce installation times and improve structural integrity — unlocking better unit economics for project developers. Learn more about VesprSolar →
Exum Instruments Launches $15M Series B to Accelerate Growth
Exum Instruments is launching a $15M Series B and actively seeking a lead investor to price the round. The team is building on strong commercial momentum and is pursuing strategic introductions — including with Hitachi and broker-dealer partners — to support its next phase of growth across industrial and scientific markets. Learn more about Exum Instruments
Cadenza Bio entered 2025 with strong momentum following a transformative year marked by key scientific and strategic milestones.
The company advanced its novel platform for G protein-coupled receptor (GPCR) stabilization, enabling faster discovery of previously intractable drug targets. Its lead program in oncology achieved preclinical proof-of-concept, positioning it for IND-enabling studies by Q3 2025. Cadenza expanded its pharma partnerships, adding two new collaborators and securing non-dilutive capital to fuel platform development. With its seed round successfully closed and an experienced team in place, Cadenza is now poised to raise a Series A to scale its pipeline and platform toward first-in-human studies. Learn more about Cadenza Bio.
Vinsense enters 2025 with strong momentum and promising strategic partnerships. The team is finalizing a revenue-sharing agreement with AgTechLogic and planning a joint pilot with Jackson Family Wines. CTOMinerva Dorantes will pitch as a finalist in the UC ANR VINE Connect accelerator, while the company continues refining its strategy with Innovatemap. Vinsense is extending its bridge round by $950K under previous terms and operating with a leaner burn rate. With a newly restructured board and renewed investor engagement, the company is well-positioned for growth. Learn more about VinSense.
Leadership Highlights:
James Spann – Expanding the Boyd Street Vision
Founder & GP James Spann continues to represent BSV at influential platforms shaping the future of capital, innovation, and global partnerships:
Selected Judge, Ernest & Young Entrepreneur of the Year – Southwest
Selected Delegate, Qatar-Bloomberg Economic Forum
Attended RESI JPM, San Francisco
Selected Member Institute for Private Investors
Acknowledged for his 10 years serving on the Stephenson School of Biomedical Engineering (SBME) board at OU (As seen in image below)
Slated to speak at upcoming conferences across venture and capital innovation
Advisor Spotlight:
Lisa Risser – Financial Empowerment through Fearless Money Management
BSV Advisor Lisa Risser has soft-launched Fearless Money Management, a platform empowering women and families through personalized financial coaching. Explore →
Sowmya Sridhar Joins WomenExecs on Boards
Sowmya Sridhar has joined WomenExecs on Boards (WEoB), a global network of board-ready women leaders who have completed Harvard Business School’s governance programs. As the Group EMMI Industry Co-Chair (Energy, Manufacturing, Mining, and Industrial), Sowmya is helping to advance board diversity and corporate governance excellence across critical sectors. WEoB champions gender equality and inclusivity in boardrooms worldwide. Explore →
.jpg?upscale=true&width=1120&upscale=true&name=Photo-41%20(1).jpg)
-2.jpg?upscale=true&width=240&upscale=true&name=2022.01.30%20Rachel%20Talton%20Headshot%207%20(1)-2.jpg)
-jpg.jpeg?upscale=true&width=240&upscale=true&name=marniepeterson_womeninwyoming_lindsaylintonbuk_002HR%20(1)-jpg.jpeg)
%20(1).jpg?upscale=true&width=240&upscale=true&name=bjones128-C%20(1)%20(1).jpg)
